Case report: Treatable immune-mediated severe orthostatic hypotension in SARS-CoV-2 infection

• Kenji Theiler,
• Maroussia Bronchain,
• Eric Grouzmann,
• Serge Duflon,
• Lorenz Hirt,
• Renaud Du Pasquier,
• Gérard Waeber,
• Grégoire Wuerzner,
• Karin Diserens,
• Julien F. Bally

Affiliations

Kenji Theiler

Service of Nephrology and Hypertension, Lausanne University Hospital (CHUV) and University of Lausanne, Lausanne, Switzerland

Maroussia Bronchain

Service of Neurology, Lausanne University Hospital (CHUV) and University of Lausanne, Lausanne, Switzerland

Eric Grouzmann

Laboratory of Catecholamines and Peptides, Lausanne University Hospital (CHUV) and University of Lausanne, Lausanne, Switzerland

Serge Duflon

Service of Neurology, Lausanne University Hospital (CHUV) and University of Lausanne, Lausanne, Switzerland

Lorenz Hirt

Service of Neurology, Lausanne University Hospital (CHUV) and University of Lausanne, Lausanne, Switzerland

Renaud Du Pasquier

Service of Neurology, Lausanne University Hospital (CHUV) and University of Lausanne, Lausanne, Switzerland

Gérard Waeber

Department of Medicine, Lausanne University Hospital (CHUV) and University of Lausanne, Lausanne, Switzerland

Grégoire Wuerzner

Service of Nephrology and Hypertension, Lausanne University Hospital (CHUV) and University of Lausanne, Lausanne, Switzerland

Karin Diserens

Acute Neurorehabilitation Unit, Department of Clinical Neurosciences, Lausanne University Hospital (CHUV) and University of Lausanne, Lausanne, Switzerland

Julien F. Bally

Service of Neurology, Lausanne University Hospital (CHUV) and University of Lausanne, Lausanne, Switzerland